PetIQ Inc (NASDAQ:PETQ) Insider Sells $681,400.00 in Stock

PetIQ Inc (NASDAQ:PETQ) insider Will Santana sold 20,000 shares of the stock in a transaction dated Wednesday, July 10th. The shares were sold at an average price of $34.07, for a total value of $681,400.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Will Santana also recently made the following trade(s):

  • On Wednesday, June 26th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $30.02, for a total value of $600,400.00.
  • On Tuesday, June 4th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $27.46, for a total value of $549,200.00.
  • On Thursday, May 23rd, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $28.16, for a total value of $563,200.00.
  • On Tuesday, May 7th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $27.85, for a total value of $557,000.00.
  • On Wednesday, April 24th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $30.77, for a total value of $615,400.00.

Shares of PETQ stock opened at $34.44 on Friday. The company has a 50-day moving average price of $30.42. The company has a quick ratio of 1.51, a current ratio of 2.89 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $971.21 million, a price-to-earnings ratio of 27.55, a PEG ratio of 1.84 and a beta of 2.06. PetIQ Inc has a fifty-two week low of $21.29 and a fifty-two week high of $43.93.



PetIQ (NASDAQ:PETQ) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.19. The business had revenue of $148.44 million for the quarter, compared to analyst estimates of $139.03 million. PetIQ had a return on equity of 9.47% and a net margin of 0.51%. On average, equities analysts expect that PetIQ Inc will post 0.74 earnings per share for the current year.

PETQ has been the subject of a number of research analyst reports. BidaskClub upgraded Misonix from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, July 3rd. Guggenheim reissued a “buy” rating and issued a $95.00 price objective (up from $90.00) on shares of VF in a report on Thursday, May 23rd. Finally, Zacks Investment Research lowered ExlService from a “hold” rating to a “sell” rating in a report on Wednesday. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $40.71.

Several hedge funds have recently made changes to their positions in the company. Citigroup Inc. increased its holdings in shares of PetIQ by 43.5% in the fourth quarter. Citigroup Inc. now owns 1,827 shares of the company’s stock valued at $43,000 after purchasing an additional 554 shares during the period. Campbell Newman Asset Management Inc. grew its holdings in PetIQ by 3.8% during the first quarter. Campbell Newman Asset Management Inc. now owns 18,080 shares of the company’s stock worth $568,000 after acquiring an additional 658 shares during the period. Legal & General Group Plc grew its holdings in PetIQ by 42.6% during the fourth quarter. Legal & General Group Plc now owns 2,451 shares of the company’s stock worth $58,000 after acquiring an additional 732 shares during the period. Brown Advisory Inc. grew its holdings in PetIQ by 4.5% during the fourth quarter. Brown Advisory Inc. now owns 16,970 shares of the company’s stock worth $399,000 after acquiring an additional 733 shares during the period. Finally, Manchester Capital Management LLC acquired a new stake in PetIQ during the first quarter worth about $30,000. 91.87% of the stock is currently owned by institutional investors and hedge funds.

About PetIQ

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

See Also: How does a reverse stock split work?

Insider Buying and Selling by Quarter for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.